Case File
efta-01461475DOJ Data Set 10OtherEFTA01461475
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-01461475
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
Description
Trade Date
Quantity
Last Prices Unit Cost
Market Value
Unrealized G/L
SANGAMO BIOSCIENCES
05/28/2013
50,000.00
$
19.80
$
8.44
$
990,000.00
$
567,786.00
BIOGEN
02/14/2012
2,095.00
$
312.60
$
119.55
$
654,897.00
$
404,442.05
FOUNDATION MEDICINE
01/13/2014
25,000.00
$
36.40
$
27.51
910,000.00
$
222,336.50
GILEAD SCIENCES INC
2/5/14, 3/7/14
8,100.00
$
72.13
$
79.41
$
584,253.00
$
(58,951.00)
ARIAD PHARMACEUTICALS
2/14/12, 1/24/13
16,535.00
$
7.60
$
17.60
$
125,666.00
$ (165,331.40)
Total Biotec $3,264,816.00
$ 970,282.15
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
CONFIDENTIAL
DB-SDNY-0 123547
SDNY_GM_00269731
EFTA01461475
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.